ENABLE SEAMLESS CANADA–US CROSS-BORDER SUPPLY TO PREVENT CUSTOMS DELAYS AND PROTECT COMMERCIAL PRODUCT FLOW

Cross-border pharmaceutical supply must navigate regulatory requirements, customs inspections, and compliance obligations to maintain reliable product availability. Incorporate strategies to comply with U.S. Drug Supply Chain Security Act (DSCSA) requirements while protecting service levels and operational efficiency.

Take away best practice to:

• Understand key DSCSA requirements, including serialization, traceability, and verification for U.S.-bound products
• Identify common customs and regulatory bottlenecks between Canada and the U.S.
• Align manufacturing, supply, and quality teams to prevent product holds and disruptions
• Implement tools and technology to streamline cross-border compliance and maintain service levels

Strengthen Canada – U.S. supply continuity by ensuring regulatory compliance and proactive risk management for commercial product flow.